ArticleCancer immunology, immunotherapy : CII2023

MIP3α as an early prognostic predictor for patients with B-cell malignancies receiving CD19/CD22-redirected CAR-T cell cocktail therapy.

Jin Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.